# A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)

> **NCT06701305** · PHASE1 · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 48 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** Efinopegdutide
- **DRUG:** Placebo
- **DRUG:** Acetaminophen

## Key facts

- **NCT ID:** NCT06701305
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-06-13
- **Primary completion:** 2025-02-18
- **Final completion:** 2025-02-18
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2025-02-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06701305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06701305, "A Study of Efinopegdutide in Healthy Obese Participants (MK-6024-015)". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT06701305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*